Curcumin anti-inflammatory and antitumorigenic effect on arteriovenous fistula maturation in patient with end-stage renal disease with diabetes mellitus
Article Sidebar
-
Acetylsalicylic Acid, Arteriovenous fistula, Curcumin, Matrix Metalloproteinase 9, Nitric Oxide
Abstract
The primary clinical problem of arteriovenous fistula (AVF) is the high maturation failure rate. Curcumin shows anti-inflammatory, antioxidant, antitumorigenic, and antiproliferative effects that may contribute to AVF maturation. This study investigated the effectiveness of curcumin and acetylsalicylic acid on anti-inflammatory and antitumorigenic effects on AVF maturation in patients with End-Stage Renal Disease (ESRD) with diabetes mellitus (DM). The present study is a single-blinded, randomized controlled trial consisting of curcumin, acetylsalicylic acid, or placebo intervention for eight weeks. A total of 67 participants completed the intervention. There was a higher level of nitric oxide (NO) between the curcumin and placebo four weeks (92.58±24.70 vs 75.67±16.50 µmol/L, adjusted p = 0.038) and eight weeks (95.27±28.77 vs 76.66±23.24 µmol/L, adjusted p <0.05) postoperatively. Higher-level of NO between acetylsalicylic acid and placebo (93.65±24.65 vs 75.67±16.50 µmol/L, adjusted p = 0.031) four weeks postoperatively. Curcumin increases NO after four and eight weeks and lowers MMP-9 four weeks after AVF operation. Acetylsalicylic acid increases NO four weeks after AVF surgery on ESRD patients with DM.
Full text article
References
Berceli, S. A., Jiang, Z., Klingman, N. V., Schultz, G. S., Ozaki, C. K. 2006. Early Differential MMP-2 and -9 Dynamics During Flow-Induced Arterial and Vein Graft Adaptations. Journal of Surgical Research, 134(2):327–334. ISSN: 0022-4804.
Bøtker, H. E., Møller, N. 2013. ON NO—The Continuing Story of Nitric Oxide, Diabetes, and Cardiovascular Disease. Diabetes, 62(8):2645–2647. ISSN: 0012-1797, 1939-327X.
Bylsma, L. C., Gage, S. M., Reichert, H., Dahl, S. L. M., Lawson, J. H. 2017. Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes. European Journal of Vascular and Endovascular Surgery, 54(4):513–522. ISSN: 1078-5884.
Eknoyan, G., Lameire, N., Eckardt, K., Kasiske, B., Wheeler, D., Levin, A., Levey, A. S. 2013. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int, 3(1):5–14.
GBD 2015 Mortality and Causes of Death Collaborators 2015. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study. Lancet, 388(10053):31012–31013.
Geenen, I. L., Kolk, F. F., Molin, D. G., Wagenaar, A., Compeer, M. G., Tordoir, J. H., Schurink, G. W., De Mey, J. G., Post, M. J. 2016. Nitric Oxide Resistance Reduces Arteriovenous Fistula Maturation in Chronic Kidney Disease in Rats. PLOS ONE, 11(1):e0146212. ISSN: 1932-6203.
Guo, N., Chen, F., Zhou, J., Fang, Y., Li, H., Luo, Y., Zhang, Y. 2015. Curcumin Attenuates Rapamycin-induced Cell Injury of Vascular Endothelial Cells. Journal of Cardiovascular Pharmacology, 66(4):338–346.
Hewlings, S., Kalman, D. 2017. Curcumin: A Review of Its Effects on Human Health. Foods, 6(10):92. ISSN: 2304-8158.
Hua, Y., Xue, J., Sun, F., Zhu, L., Xie, M. 2009. Aspirin Inhibits MMP-2 and MMP-9 Expressions and Activities through Upregulation of PPARα/γ and TIMP Gene Expressions in ox-LDL-Stimulated Macrophages Derived from Human Monocytes. Pharmacology, 83(1):18–25. ISSN: 0031-7012, 1423-0313.
Kim, J. Y., Kim, W. J., Kim, H., Suk, K., Lee, W. H. 2009. The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-κB in Macrophages: Implication for Atherosclerosis. Immune Network, 9(3).
Kuliczkowski, W., Radomski, M., Gąsior, M., Urbaniak, J., Kaczmarski, J., Mysiak, A., Negrusz-Kawecka, M., Bil-Lula, I. 2017. MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study. BioMed Research International, 2017:1–12. ISSN: 2314-6133, 2314-6141.
Lee, E. S., Shen, Q., Pitts, R. L., Guo, M., Wu, M. H., Yuan, S. Y. 2010. Vein Tissue Expression of Matrix Metalloproteinase as Biomarker for Hemodialysis Arteriovenous Fistula Maturation. Vascular and Endovascular Surgery, 44(8):674–679. ISSN: 1538-5744, 1938-9116.
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., Graham, J., Moist, L. M., Rajan, D. K., Roberts, C., Vachharajani, T. J., Valentini, R. P. 2020. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases, 75(4):S1–S164. ISSN: 0272-6386.
Luyckx, V. A., Tonelli, M., Stanifer, J. W. 2018. The global burden of kidney disease and the sustainable development goals. Bulletin of the World Health Organization, 96(6):414–422D. ISSN: 0042-9686.
Misra, S., Fu, A. A., Anderson, J. L., Sethi, S., Glockner, J. F., McKusick, M. A., Bjarnason, H., Woodrum, D. A., Mukhopadhyay, D. 2008. The Rat Femoral Arteriovenous Fistula Model: Increased Expression of Matrix Metalloproteinase–2 and 9 at the Venous Stenosis. Journal of Vascular and Interventional Radiology, 19(4):587–594. ISSN: 1051-0443.
Pae, H. O., Jeong, G. S., Jeong, S. O., Kim, H. S., Kim, S. A., Kim, Y. C., Yoo, S. J., Kim, H. D., Chung, H. T. 2007. Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. Experimental and Molecular Medicine, 39(3):267–277.
Pratama, D., Yuwono, H. S., Supriyadi, R., Herman, H., Damara, F. A., Akbar, A. 2020. Antioxidant Properties of Curcumin and Its Impact on Arteriovenous Fistula Maturation in End-Stage Kidney Disease Patient with Diabetes Mellitus Type 2. International Journal of Research in Pharmaceutical Sciences, 11(4):7624–7629. ISSN: 0975-7538.
Santos-Parker, J. R., Strahler, T. R., Bassett, C. J., Bispham, N. Z., Chonchol, M. B., Seals, D. R. 2017. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging, 9(1):187–208. ISSN: 1945-4589.
Schröder, H. 2009. Nitric oxide and aspirin: a new mediator for an old drug. American Journal of Therapeutics, 16(1):17–23.
Smith, G. E., Gohil, R., Chetter, I. C. 2012. Factors affecting the patency of arteriovenous fistulas for dialysis access. Journal of Vascular Surgery, 55(3):849–855. ISSN: 0741-5214.
Soo, C., Shaw, W. W., Zhang, X., Longaker, M. T., Howard, E. W., Ting, K. 2000. Differential Expression of Matrix Metalloproteinases and Their Tissue-Derived Inhibitors in Cutaneous Wound Repair. Plastic and Reconstructive Surgery, 105(2):638–647. ISSN: 0032-1052.
Taubert, D., Berkels, R., Grosser, N., Schröder, H., Gründemann, D., Schömig, E. 2004. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. British Journal of Pharmacology, 143(1):159–165. ISSN: 0007-1188.
Tessari, P., Cecchet, D., Cosma, A., Vettore, M., Coracina, A., Millioni, R., Iori, E., Puricelli, L., Avogaro, A., Vedovato, M. 2010. Nitric Oxide Synthesis Is Reduced in Subjects with Type 2 Diabetes and Nephropathy. Diabetes, 59(9):2152–2159. ISSN: 0012-1797, 1939-327X.
Wang, X., Khalil, R. A. 2018. Matrix Metalloproteinases, Vascular Remodeling and Vascular Disease. Advances in Pharmacology, 81:241–330.
Webb, A. H., Gao, B. T., Goldsmith, Z. K., Irvine, A. S., Saleh, N., Lee, R. P., Lendermon, J. B., Bheemreddy, R., Zhang, Q., Brennan, R. C., Johnson, D., Steinle, J. J., Wilson, M. W., Vanessa M. Morales-Tirado 2017. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer, 17(1). ISSN: 1471-2407.
Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E., Lindsey, M. L. 2013. Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease. Physiology, 28(6):391–403. ISSN: 1548-9213, 1548-9221.
Yan, Y., Ye, D., Yang, L., Ye, W., Zhan, D., Zhang, L., Xiao, J., Zeng, Y., Chen, Q. 2018. A meta-analysis of the association between diabetic patients and AVF failure in dialysis. Renal Failure, 40(1):379–383. ISSN: 0886-022X, 1525-6049.
Yang, X., Thomas, D. P., Zhang, X., Culver, B. W., Alexander, B. M., Murdoch, W. J., Rao, M. N., Tulis, D. A., Ren, J., Sreejayan, N. 2006. Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(1):85–90. ISSN: 1079-5642, 1524-4636.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.